Fractal and reactive dimensions of some ursodeoxycholic acid salts

International Journal of Pharmaceutics

Volumn 171, Issue 1, 1998, Pages 45-52

  Fini, Adamo ^a   Fazio, Giuseppe ^a   Holgado, Maria Angeles ^a   Fernàndez Hervàs, Maria José ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Fractal analysis; Fractal and reactive dimensions; Lyophilization; Thermal analysis; Ursodeoxycholic acid salts

Indexed keywords

INORGANIC SALT; URSODEOXYCHOLIC ACID;

DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; FRACTAL ANALYSIS; FREEZE DRYING; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SHORT SURVEY; SURFACE PROPERTY; THERMAL ANALYSIS;

EID: 0032581796     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00168-9     Document Type: Article

References (16)

1. Carey, M.C., Small, D.M., 1969. Micellar properties of dihydroxy and trihydroxy bile salts. Effects of counterion and temperature. J. Colloid Interface Sci. 31, 382-396.
2. Farin, D., Avnir, D., 1987. Reactive fractal surfaces. J. Phys. Chem. 91, 5517-5521.
3. Fernàndez-Hervàs, M.J., Holgado, M.A., Rabasco, A.M., Fini, A., 1994. Use of a fractal geometry on the characterization of a particle morphology: application to the diclofenac-hydroxyethylpyrrolidine salt. Int. J. Pharm. 108, 187-194.
4. Fini, A., 1989. The physical chemical properties of bile acids and their role in drug delivery. In: Breimer, D.D., Crommelin, D.J.A., Midha, K.K. (Eds.). Topics in Pharmaceutical Sciences. F.I.P., The Hague, The Netherlands, pp. 459-471.
5. Fini, A., Fazio, G., Orienti, I., Zecchi, V., Rapaport, I., 1991. Chemical properties-dissolution relationship, IV. Behaviour in solution of diclofenac-N-(2-hydroxyethyl) pyrrolidine (DHEP). Pharm. Acta Helv. 66, 201-203.
6. Fini, A., Fazio, G., Fernàndez-Hervàs, M.J., Holgado, M.A., Rabasco, A.M., 1996a. Factors governing the dissolution of diclofenac salts. Eur. J. Pharm. Sci. 4, 231-238.
7. Fini, A., Fazio, G., Fernàndez-Hervàs, M.J., Holgado, M.A., Rabasco, A.M., 1996b. Fractal analysis of sodium cholate particles. J. Pharm. Sci. 85, 971-975.
8. Fini, A., Fernàndez-Hervàs, M.J., Holgado, M.A., Rabasco, A.M., 1996c. Characterization of drug particles using the parameters of the fractal geometry. Acta Technol. Leg. Med. 7, 41-56.
9. Fini, A., Feroci, G., Fazio, G., Fernàndez-Hervàs, M.J., Holgado, M.A., Rabasco, A.M., 1996d. Effects of the counterions on the properties of diclofenac salts. Intl. J. Pharm. Adv. 1, 269-284.
10. Fini, A., Fernàndez-Hervàs, M.J., Holgado, M.A., et al., 1997. Fractal analysis of β-cyclodextrin-indomethacin particles compacted by ultrasound. J. Pharm. Sci. 86, 1303-1309.
11. Gu, L., Strickley, R.G., 1987. Preformulation salt selection. Physical property comparisons of the tris(hydroxymethyl)aminomethane (THAM) salts of four analgesic/ antiinflammatory agents with the sodium salts and the free acids. Pharm. Res. 4, 255-257.
12. Hofmann, A.F., 1984. Chemistry and enterohepatic circulation of bile acids. Hepatology 4, 4S-14S.
13. Maggi, C.A., Lualdi, P., Mautone, G., 1990. Comparative bioavailability of diclofenac hydroxyethyl pyrrolidine vs. diclofenac sodium. Eur. J. Clin. Pharmacol. 38, 207-208.
14. Makino, I., Shinozaki, K., Yoshino, K., Nakagawa, S., 1975. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jpn. J. Gastroenterol. 72, 690-702.
15. Perrin, D.D., Dempsey, B., 1974. Buffers for pH and Metal Ion Control. Chapman and Hall, London, p. 59.
16. Roda, A., Minutello, A., Angellotti, M.A., Fini, A., 1990. Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol-water partition coefficient and reverse phase HPLC. J. Lipid Res. 31, 1433-1443.